What's Happening?
Dr. Kara Leigh Roncin, a pathologist at CHI Health, has been featured in the December 2025/January 2026 issue of Forbes magazine. Dr. Roncin specializes in breast pathology and has been recognized for her professional achievements and industry expertise.
She holds dual board certifications in anatomic and clinical pathology from the American Board of Pathology. Her career includes significant roles such as chairperson of the Commission on Cancer/Network Cancer Committee and pathology lead for the Network Cancer Committee and the Breast Health Professional Advisory Board. Dr. Roncin has also served on the Non-Small Cell Lung Carcinoma Biomarker Testing Learning Collaborative with the American Society of Clinical Pathology. Her educational background includes a Bachelor of Science in anatomy and cell biology from the University of Saskatchewan and a Doctor of Medicine from the Medical University of the Americas.
Why It's Important?
Dr. Roncin's recognition in Forbes highlights her contributions to the field of pathology, particularly in breast pathology. Her work is significant in advancing medical research and improving cancer treatment protocols. As a member of various pathology societies, Dr. Roncin's influence extends to shaping best practices and standards in pathology. Her leadership roles in cancer committees underscore her commitment to improving cancer care and outcomes. This recognition not only celebrates her achievements but also brings attention to the critical role pathologists play in healthcare, potentially inspiring future medical professionals to pursue careers in pathology.
